Illumina Body Map 2
Name | miRBASE accession |
---|---|
hsa-miR-214-5p
|
MIMAT0004564 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_19157248 Show fit | 0.38 |
ENST00000242261.5
|
twist family bHLH transcription factor 1 |
|
chr11_+_76494253 Show fit | 0.29 |
ENST00000333090.4
|
tsukushi, small leucine rich proteoglycan |
|
chr2_-_19558373 Show fit | 0.29 |
ENST00000272223.2
|
odd-skipped related transciption factor 1 |
|
chr2_-_217560248 Show fit | 0.25 |
ENST00000233813.4
|
insulin-like growth factor binding protein 5 |
|
chr6_-_39197226 Show fit | 0.24 |
ENST00000359534.3
|
potassium channel, subfamily K, member 5 |
|
chr4_+_55095264 Show fit | 0.23 |
ENST00000257290.5
|
platelet-derived growth factor receptor, alpha polypeptide |
|
chr1_+_39957292 Show fit | 0.22 |
ENST00000331593.5
|
bone morphogenetic protein 8a |
|
chrX_+_99839799 Show fit | 0.20 |
ENST00000373031.4
|
tenomodulin |
|
chr6_+_21593972 Show fit | 0.18 |
ENST00000244745.1
ENST00000543472.1 |
SRY (sex determining region Y)-box 4 |
|
chr3_+_37493610 Show fit | 0.17 |
ENST00000264741.5
|
integrin, alpha 9 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:2000276 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
0.1 | 0.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.3 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.1 | 0.3 | GO:0023016 | osmosensory signaling pathway(GO:0007231) signal transduction by trans-phosphorylation(GO:0023016) kidney smooth muscle tissue development(GO:0072194) pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.2 | GO:0035910 | N-terminal peptidyl-lysine acetylation(GO:0018076) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.0 | 0.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.0 | 0.2 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.2 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.0 | 0.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.1 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.3 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.2 | GO:0005018 | platelet-derived growth factor alpha-receptor activity(GO:0005018) |
0.0 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.1 | GO:0070984 | SET domain binding(GO:0070984) |
0.0 | 0.1 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 0.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.0 | 0.0 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.0 | 0.0 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |